EMA Authorised: Emtriva (emtricitabine) — Gilead Sciences Ireland UC

View source ↗

Summary

Emtriva (emtricitabine) has been authorised by the EMA for HIV infections in the European Union.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Emtriva (emtricitabine)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Gilead Sciences Ireland UC. Decision date: 18/04/2023